Your Messages Inbox
Your Article Summary
See Latest ArticlesFDA Approves Boston Scientific's Apex PTCA Dilatation Catheter
Boston Scientific, 01/06/09
Boston Scientific Corporation announced that it has received approval from the U.S. Food and Drug Administration to market its Apex PTCA(1) Dilatation Catheter. The Apex Catheter is a high-performance pre-dilatation balloon catheter developed specifically to address physicians' needs in treating the most challenging atherosclerotic lesions. It is available for distribution in both Monorail and Over-The-Wire (OTW) catheter platforms.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor